Issues
Volume 207 Issue 6
News
News briefs
Methamphetamine use linked to stroke in young people The stimulant methamphetamine, also known as “speed”, “ice” and “meth”, is linked to a heightened risk of stroke among young people, according to a review of the available evidence by authors from the National Drug and Alcohol Research Centre, published in the Journal of Neurology, Neurosurgery and Psychiatry. Haemorrhagic stroke is more commonly associated with the use of this drug than ischaemic stroke, with men twice as likely to succumb as women, the findings show. The authors were looking for a potential link between methamphetamine use and associated stroke risk in young people (under the age of 45 years), and their findings were based on a review of 370 articles published to February 2017, of which 77 case reports and series were selected for analysis. Some 81 haemorrhagic and 17 ischaemic strokes were reported. Both types were about twice as common in men as they were in women. In the case reports and series, eight of ten strokes associated with methamphetamine use by young people were haemorrhagic. This rate is much higher than reported rates of this type of stroke in people under the age of 45 years (40–50%) or in older people (15–20%), the researchers emphasised. Methamphetamine can be swallowed, inhaled or injected; haemorrhagic strokes were associated with swallowing or injecting the drug, while inhalation was the most common route associated with ischaemic stroke. Haemorrhagic stroke was associated with vascular abnormalities, such as high blood pressure and vasculitis, in one-third of cases. Repeated use of methamphetamine can increase blood pressure even in people whose blood pressure is initially normal, say the researchers. Risk of death was also higher after a haemorrhagic stroke: one in four people recovered completely, but one-third died. This compares with complete recovery for one in five people and death in one in five after an ischaemic stroke. http://jnnp.bmj.com/content/early/2017/08/01/jnnp-2017-316071 Less REM sleep associated with greater risk of dementia Research from Swinburne University of Technology in Melbourne has found that dementia in the elderly may be predicted by measuring rapid eye movement (REM) sleep. The study, published in Neurology, found that for every percentage point that REM sleep was reduced in older people, there was a nine-fold increase in the risk of their developing dementia. Researchers analysed data for 321 people with an average age of 67 years who participated in the United States-based Framingham Heart Study. During the study, their sleep cycles were assessed. Researchers then followed the participants for an average of 12 years. During that time, 32 people were diagnosed with some form of dementia, including 24 with Alzheimer disease. The participants who developed dementia spent an average of 17% of their sleep time in REM sleep, compared with 20% for the people who did not develop dementia. After adjusting for age and sex, researchers found that a lower percentage of REM sleep and a longer time to reach the REM sleep stage were each associated with a greater risk of dementia. The results were similar after researchers adjusted for other factors that could affect dementia risk or sleep, such as heart disease factors, depression symptoms and medication use. Changes in other stages of sleep were not associated with an increased dementia risk. http://www.neurology.org/content/early/2017/08/23/WNL.0000000000004373
Cate Swannell
Perspectives
Understanding and managing the health impacts of poor air quality from landscape fires
Australians need to get better at dealing with episodic smoke events
Fay H Johnston
Public reporting of clinician-level data
There is much debate about public disclosure of individual doctors’ performance to increase hospital quality and safety, but research is lacking
Rachel Canaway · Marie M Bismark · David Dunt · Margaret A Kelaher
Extreme heat threatens the health of Australians
Heatwaves have serious health impacts and we need a better approach to prevention and management
Marion G Carey · Mark P Monaghan · Fiona J Stanley
Thunderstorm asthma outbreak of November 2016: a natural disaster requiring planning
Learning from a tragedy to increase public awareness and improve responses in future thunderstorm asthma events
Steven J Lindstrom · Jeremy D Silver · Michael F Sutherland · Andrew BA Treloar · Ed Newbigin · Christine F McDonald · Jo A Douglass
Medical education
Von Meyenburg complexes in a patient with obstructive jaundice
Biliary hamartomas were an incidental finding in a 33-year-old man who was investigated for recurrent episodes of biliary colic
Vipin Gupta · Govind Makharia
Book/Media/App review
Insights into the origin and identity of the discipline of public health
Public health: a very short introduction
James M Trauer
Obituary
Geoffrey Laurence Driscoll, OAM, FRCSEd, FRANZCOG, FRCOG
13 March 1947 - 5 October 2016
David Molloy
Editorials
Is inpatient rehabilitation after a routine total knee replacement justified?
More expensive treatment options do not always achieve better outcomes
Andreas Loefler
Reducing the rate of serious injuries to cyclists
Comprehensive application of the Safe System approach is needed to protect vulnerable road users
Raphael H Grzebieta · Jake Olivier · Soufiane Boufous
Research
Road safety: serious injuries remain a major unsolved problem
Fatality rates have been reduced, but greater attention to preventing serious injury is needed
Ben Beck · Peter A Cameron · Mark C Fitzgerald · Rodney T Judson · Warwick Teague · Ronan A Lyons · Belinda J Gabbe
The value of inpatient rehabilitation after uncomplicated knee arthroplasty: a propensity score analysis
Joint replacement outcomes do not justify the costs of inpatient rehabilitation for many patients
Justine Maree Naylor · Andrew Hart · Rajat Mittal · Ian Harris · Wei Xuan
Cataract surgery coverage rates for Indigenous and non-Indigenous Australians: the National Eye Health Survey
The availability and use of cataract services in Indigenous communities must be improved
Joshua Foreman · Jing Xie · Stuart Keel · Peter van Wijngaarden · Jonathan Crowston · Hugh R Taylor · Mohamed Dirani
Narrative review
REM sleep behaviour disorder: not just a bad dream
Treatment is effective and involves treatment of underlying causes, modification of the sleep environment, and pharmacotherapy
Elie Matar · Simon JG Lewis
Letters
Influence of birth month on the probability of Western Australian children being treated for ADHD
To the Editor:Whitely and colleagues1 reported that children born in June were more likely to receive treatment for attention deficit/hyperactivity disorder (ADHD) than children born in July. It is unfortunate that they did not measure the year of school intake, and rather made the assumption that all children entered school at the recommended age. The authors concluded that “there are significant concerns about the validity of ADHD as a diagnosis,” which is a large leap not substantiated by the data presented. We are conducting Australia’s first community-based longitudinal study of children with (n = 179) and without ADHD (n = 212), the Children’s Attention Project.2,3 Our design is ideal for examining this research question as children were all recruited across one year of school, enabling us to accurately categorise children as early or late starters. We rigorously assessed for ADHD (ie, via parent and teacher surveys and diagnostic interviews) and also recorded the use of ADHD medications. To investigate the same question within our cohort, we defined early starters as those children with birth months in February, March or April (age at entry, 4 years 9 months to 4 years 11 months; n = 46) and late starters as those children born in May, June or July (age at entry, 5 years 6 months to 5 years 8 months; n = 123). We found no relationship between being an early or late starter and meeting the criteria for ADHD at either age 7 years or age 10 years. Our sample size for these analyses was small because most children with ADHD were born outside the months encapsulating early and late start date definitions (n = 112; 63% of our ADHD sample). Only nine children were prescribed medication across the early and late starter definitions — one early starter and eight late starters. In conclusion, our data show that when school commencement year is considered, there is little evidence to support early versus late school starter status as a predictor of ADHD and treatment in Victoria. The overall rate of ADHD medication prescribing for children aged 6–15 years reported by Whitely and colleagues was 1.9%.1 ADHD has a prevalence of about 5%,4 thus, these data provide further reassurance that the rates of prescribing of ADHD medications in Australia remain moderate.
Emma Sciberras · Alisha Gulenc · Daryl Efron
Influence of birth month on the probability of Western Australian children being treated for ADHD
In reply
Martin Whitely · John Phillimore · Leanne Lester · Suzanne Robinson
Invasive Neisseria gonorrhoeae producing pre-septal cellulitis and keratoconjunctivitis: diagnosis and management
To the Editor: A 53-year-old woman experienced rapid onset of left eyelid pain, swelling and purulent discharge (Box 1). She presented to our eye hospital 3 days later and, on assessment, the lids were exquisitely tender, inflamed and difficult to open. There was chemosis, microcystic corneal oedema with Descemet membrane folds and moderate inflammation in the anterior chamber. Visual acuity was 6/24 in the left eye and 6/9 in the right eye. Ocular motility appeared normal. The severe inflammation and visual impairment raised concerns for post-septal orbital cellulitis. A computed tomography scan showed severe pre-septal stranding only (Box 2). A diagnosis of left pre-septal cellulitis and keratoconjunctivitis was made. She was given intravenous ceftriaxone 2 g daily, intravenous flucloxacillin 2 g four times a day, topical chloramphenicol 0.5% four times a day and regular eye washings. Microscopy found gram-negative diplococci, and polymerase chain reaction testing was positive for Neisseria gonorrhoeae. The patient denied history of sexually transmissible infection. A urine and serum sexually transmissible infection screen for N. gonorrhoeae, Chlamydia trachomatis and blood-borne viruses was negative. Treatment was rationalised to intravenous ceftriaxone 1 g daily, with a single 1 g dose of oral azithromycin. The patient had dramatic improvement over 4 days, and visual acuity improved to 6/7.5 at discharge (Box 3). One week later, the infection had predominately resolved. N. gonorrhoeae typically produces a hyperacute unilateral conjunctivitis. While the source of infection in this patient is unclear, in most cases infection is acquired via sexual transmission and reaches the conjunctiva through hand–eye auto-inoculation.1,2 The bacteria can invade the corneal epithelium, producing keratitis and corneal melting necessitating therapeutic keratoplasty.1,2 Gonococcal periorbital infection is rare, with only three cases of pre-septal cellulitis and two cases of post-septal cellulitis reported.3 All patients were successfully treated with parenteral antibiotics. N. gonorrhoeae has increasing antimicrobial resistance, creating a therapeutic challenge. The Australian Gonococcal Surveillance Programme has shown an emerging resistance to ceftriaxone — the antibiotic of choice — from 0.6% in 2006 to 5.4% in 2014.4 Azithromycin resistance occurs in 2.4% of strains.4 The Australian Therapeutic Guidelines recommend treatment of N. gonorrhoeae with parenteral ceftriaxone and oral azithromycin, for bactericidal synergy and cotreatment for C. trachomatis. When presented with pre-septal cellulitis and purulent keratoconjunctivitis, the clinician should be vigilant for a sight-threatening N. gonorrhoeae infection. Box 1 – Lid inflammation and purulent discharge at onset, 3 days before presentation Box 2 – Contrast-enhanced computed tomography scan showing significant pre-septal subcutaneous stranding (blue arrow) and severe conjunctival chemosis (yellow arrow) Box 3 – Marked improvement in periorbital inflammation after 3 days of antibiotic therapy, with residual conjunctival injection
Shivesh Varma · Nathan Wong · Jwu Jin Khong
The obesity epidemic and sugar-sweetened beverages: a taxing time
To the Editor:We fully support Colagiuri’s appeal to implement comprehensive, regulatory action to reduce sugar-sweetened beverage consumption.1 Excessive sugar-sweetened soft drink consumption is associated with weight gain, diabetes and dental caries.2 Strikingly, sugary drinks are the single largest contributor of added sugars in the diet of Australians aged 14–50 years.3 In recognition that environmental changes can support healthier consumer choices, the New South Wales government has pledged to remove sugary drinks for sale from all its health facilities by December 2017.4 This follows the lead of 13 health services in Victoria that have also adopted this health-promoting policy. Media coverage of these measures has been positive,4 as communities look to health centres to be leaders in supporting and protecting public health. In contrast, Australian university campuses, including those with medical schools responsible for developing future health leaders, remain saturated in soft drink promotions and sales. Detractors of policy-based approaches suggest that education efforts and offering healthy choices are preferable to “nanny state” restrictions. Health education campaigns that advise people to restrict their consumption of sugary drinks must battle against the ubiquitous advertising and availability of these products. In the United States, it is well documented that the university food environment is shaped by purveyors of unhealthy food and drink.5 “Free choice” arguments ignore the realities of sales contracts that include exclusively selling certain brands and products. Similarly, in Australia, exclusive sales contracts offered to suppliers may restrict the choices of staff and students on campus. The real issue appears to be the unfounded fear that banning the sale of soft drinks on campuses may have negative revenue implications. This fails to acknowledge that replacement beverages that are not sugar-sweetened could still be sold. Australian university campuses have readily banned smoking and the sale of tobacco without experiencing financial hardship as a consequence. Universities, especially those training future health professionals, need to flex their collective muscle and be part of the momentum towards creating healthy environments. Initiating healthy beverage policies is a significant step forward.
Becky Freeman · Kieron Rooney · Eloise Howse
Family violence: an illustrated guide to the terminology
To the Editor:Recent reports from the World Health Organization1 and from Australian agencies2,3 emphasise the urgency of improving health service response to family violence. Understanding the victim and survivor experience and perpetrator patterns is essential to improving health practitioners’ capacities for recognising and responding appropriately to family violence.1,3 Although there is an increasing awareness of the severity of health consequences of family violence,1,4 there is little standardisation of terminology within the national and international literature. The Royal Australian College of General Practitioners recognises physical, emotional, economic, social, sexual, psychological, verbal and spiritual abuse as forms of family violence.4 Family violence includes any violence or abuse that occurs within a family,4 including between partners, parents, children, siblings, uncles or aunts, cousins, grandparents and in-laws. Complexities arise because of the pervasive nature of violence when trying to differentiate the types of violence and individual victims. For example, studies show that 50% of children who experienced physical abuse and 40% of children who experienced sexual abuse have a mother who experienced intimate partner violence.5 “Domestic violence” emphasises the place of the violence, whereas “family violence” emphasises the relationships between the victim and the perpetrator. “Intimate partner violence” refers to the “behaviour within an intimate relationship” of current or former partners (including same-sex relationships) causing “physical, emotional, sexual, economic and social harm to those in the relationship”.4 Family violence (Box) encompasses domestic violence, intimate partner violence and sibling violence. Cases of child neglect, child abuse, child sexual abuse, sexual assault and rape may occur in the context of family violence; however, these forms of violence may also occur outside the context of the family, such as institutional abuse or stranger violence. Likewise, older people abuse, which can include sexual abuse and rape, may occur in the context of family violence and also in institutional contexts, in the context of service provision or between people who have no familial or institutional relationships. An increased understanding of the terminology used in the research literature enhances the capacity for delivering high quality care to women, children and men experiencing the health impacts of family violence. Box – Terminology for family violence Figure by Debbi Long and Serena Lee.
Debbi Long · Serena Lee · Jan Y Coles
Careers
Around the universities and research institutes
Dr Loan Le, post-doctoral researcher in the Cardiac Regeneration Laboratory at the Westmead Institute and Cardiology Department at the Westmead Hospital, has been awarded the 2017 Ralph Reader Basic Science Prize. Dr Le received the award for her research investigating the promise of stem cell therapy in repairing damaged hearts. She said her research aims to create effective treatments for patients with injured hearts, for example after a heart attack. The Ralph Reader Prize is one of the most prestigious awards in cardiovascular research in Australasia. Dr Le was co-awarded the prize with Dr Inken Marten from the Victor Chang Cardiac Research Institute. The prize was awarded to the best individual presentation by an investigator at the recent Cardiology Society of Australian and New Zealand (CSANZ) annual meeting in Perth. The prize was awarded by a panel of judges based on the quality of research. The meeting was attended by more than 2000 cardiologists, technologists, researchers, trainees, surgeons, physicians, nurses and students. http://www.westmeadinstitute.org.au/news-and-events/2017/westmead-institute-researcher-wins-prestigious-pri Infectious diseases researcher and paediatrician, Telethon Kids Institute’s Dr Asha Bowen, has been named the Woodside Early Career Scientist of the Year at the 2017 West Australian Premier’s Science Awards. The Premier’s Science Awards recognise and celebrate the achievements of the WA science community, including outstanding scientific researchers and science engagement activities. The Institute had two other finalists in the Awards – Professor Donna Cross in the Scientist of the Year category, and the Institute’s “60 Second Science” video series, led by Professor Andrew Whitehouse and the Autism Research Team, in the Chevron Science Engagement of the Year category. Dr Asha Bowen received the award in recognition of her research to reduce the burden of infectious diseases in Aboriginal Australian children, particularly skin infections – a major cause of health problems in remote communities. Dr Bowen is currently the lead researcher in the first comprehensive skin control program for WA, a collaboration with health services and communities in the Kimberley, which aims to halve the incidence of skin infections in Kimberley Aboriginal children. She is also leading the development of national guidelines on treatment, prevention and public health control of skin infections. https://www.telethonkids.org.au/news--events/news-and-events-nav/2017/august/telethon-kids-researcher-wins-premiers-award/ Professor Kate Loveland, Research Group head at the Centre for Reproductive Health at Monash University and the Hudson Institute of Medical Research, has had her honorary title of Liebig Professor with the Justus-Liebig University (JLU) renewed, highlighting the importance of her work at the German university. Professor Loveland received the honour for her work in building the International PhD Research Training Group in the Molecular Pathogenesis of Male Reproductive Disorders (IRTG) between Monash University and JLU. This award also recognises her support in promoting and building collaboration between the two institutions with key projects, including the Erasmus-Plus program that enables mobility of staff (administration and research) and students between the two universities. The program has received more than $10 million AUD support from the German Research Foundation and over $4.5 million in cash and in kind contributions from Monash University. http://hudson.org.au/latest-news/renowned-professor-receives-international-title/ Guiying Nie, a reproductive specialist on uterine receptivity and placental development and Research Group Head, Implantation and Placental Development at the Centre for Reproductive Health at the Hudson Institute, has been promoted to Adjunct Professor. Professor Nie is a respected reproductive biologist and works closely with specialist clinicians to address key women’s health issues, with a current focus on the uterus and intrauterine environment for embryo implantation, placental development, and long-term health consequences. She is an authority on uterine receptivity and placental development. Professor Nie earned her PhD from the University of Essex in the UK, and completed her postdoctoral training at the Brookhaven National Laboratory in New York, US. She joined Prince Henry’s Institute in 1995 (now the Hudson Institute) and is a Fellow of the Society of Reproductive Biology. http://hudson.org.au/latest-news/highly-regarded-reproductive-specialist-promoted/ Professor Jock Findlay, AO, has been honoured for his service and leadership in reproductive biology research with the Society for the Study of Reproduction’s 32nd Annual Distinguished Service Award, presented at the society’s recent annual meeting in Washington, DC. This award recognises service to the discipline of reproductive biology, training postdoctoral fellows, leadership positions in the field, as well as a productive career in research. Professor Findlay is one of Australia’s leading reproductive biologists. In a career spanning five decades, he has published more than 400 journal articles, been cited more than 16 000 times, and mentored or supervised more than 30 PhD students. Raised on a sheep station near Broken Hill, in far-west NSW, Professor Findlay completed his PhD in Adelaide in 1970, before taking up post-doctoral positions in Bonn, Germany, then at the University of Melbourne. Professor Findlay joined the Medical Research Centre at Prince Henry’s Hospital (later Prince Henry’s Institute) in 1979, where he headed the Female Reproductive Biology Group. He later became Director of Research at the Royal Women’s Hospital from 2007 to 2012. Professor Findlay’s current title is Distinguished Scientist, Hudson Institute of Medical Research, and he holds Professorships at both the University of Melbourne and Monash University. http://hudson.org.au/latest-news/professor-jock-findlay-ao-receives-ssr-distinguished-service-award/
2017 Conferences in Australia and New Zealand
This calendar will be updated each month. If you have an event you would like to add, please include relevant details in an email to cswannell@mja.com.au. The full version of the calendar is available online at www.mja.com.au 2017 September 1 Epworth HealthCare 8th Obstetrics & Gynaecology Clinical Institute Symposium, Melbourne, VIC 1 QRME Ltd Cultural Safety Training: Developing positive, respectful relationships with Aboriginal and Torres Strait Islander people, create a culturally safe practice, administer the PIP – Indigenous Health Incentive, Toowoomba, QLD 1-2 Australia and New Zealand Academy for Eating Disorders 2017 Conference, Darling Harbour, NSW 1-2 Australasian Academy of Facial Plastic Surgery (AAFPS) & Blepharoplasty Australia 3rd Triennial Masters Symposium on Blepharoplasty and Facial Rejuvenation, Sydney, NSW 1-3 General Practice Conference and Exhibition, Brisbane, QLD 1-3 Australian Society of Cosmetic Dermatologists Symposium, Melbourne, VIC 2-3 QRME Ltd Advanced Lift Support: build participants’ knowledge, skills and confidence when responding to rural general practice emergencies, Toowoomba, QLD 4 Mental Health in Education Summit, Sydney, NSW 5-7 11th National Aboriginal and Torres Strait Islander Environmental Health Conference, Cairns, QLD 6 Paediatric Nephrology Update, Darwin, NT 6 VicFEAT: Paediatrics Further Education and Training 2017, Melbourne, VIC 6-7 6th Annual International Emergency Care Conference, Melbourne, VIC 6-8 2017 Australian Palliative Care Conference: Connection with community, Adelaide, SA 6-8 10th ANZSIN Meeting, Darwin, NT 8 The Alfred Emergency and Trauma Centre Resuscitation Update, Melbourne, VIC 7-9 New Zealand Sexual Health Society 39th Annual Conference, Christchurch, NZ 8-10 Joint Neuroanaesthesia and Trauma SIG Meeting, Byron Bay, NSW 8-10 International Cornea and Contact Lens 2017 Congress: See the light, Sydney, NSW 9-10 ANZCA/ASA SA NT Burnell Jose Visiting Professionals ASM: Anaesthesia and you: understanding human factors and optimising performance, Rowland Flat, SA 12-14 AACB 55th Annual Scientific Conference: Time sensitive testing, Melbourne, VIC 13-15 28th Annual Conference of the Australasian Society of Clinical Immunology and Allergy, Auckland, NZ 14 RUOK? Day 14 2017 Innovations in Cancer Treatment and Care Conference, Sydney, NSW 14-15 3rd Australian Nursing and Midwifery Conference, Newcastle, NSW 14-16 Australian Doctors’ Health Conference, Sydney, NSW 14-16 Internal Medicine Society of Australia and New Zealand Annual Conference 2017, Hobart, TAS 14-17 Neuro-Ophthalmology Society of Australia 33rd Clinical and Scientific Meeting and NeuroVision Training Weekend, Sydney, NSW 15-17 RANZP Faculty of Psychotherapy Conference 2017, Ayers Rock, NT 15-17 ASBDD Biennial Conference: Better treatments, better outcomes, Melbourne, VIC 15-17 ANZAAG Symposium: Perioperative drug hypersensitivity – working together to keep patients safe, Auckland, NZ 16 Epworth Healthcare Perioperative Medicine Symposium, Melbourne, VIC 17-20 2017 Rehabilitation Medicine Society of Australia and New Zealand 2nd ASM, Canberra, ACT 20 11th Florey International Postgraduate Research Conference, Adelaide, SA 20-22 6th APAC Forum: Lead the change you want to see, Gold Coast, QLD 20-23 AIDA Conference 2017: Family, unity, success, 20 years strong, Pokolbin, NSW 21-22 Big Data and Analytics Innovation Summit: Maximise the Potential of Your Big Data Initiatives, Sydney, NSW 22-23 Practical Management for Clinicians with Leadership Responsibilities, Queenstown, NZ 23 Trauma Radiology Course, Brisbane, QLD 25-27 RANZP New Zealand National Conference 2017: Uniting the pathways, Tauranga, NZ 25-27 9th International Global Virus Network Meeting, Melbourne, VIC 27-29 Joint 2017 ACHSM/ACHS Asia-Pacific Congress: The winds of change, adjust your sails, Sydney, NSW 29-30 Annual Scientific and Education Meeting of the Paediatric Society of Queensland, Brisbane, QLD October 3 RACP member seminar: Obesity, Canberra, ACT 3-4 2017 NDARC Annual Research Symposium, Sydney, NSW 4-6 Global Alcohol Policy 2017 Conference: Mobilising for change: Alcohol policy and the evidence for action, Melbourne, VIC 4-6 Australasian Gastro-intestinal Trials Group 19th Annual Scientific Meeting, Cairns, QLD 4-6 2017 Obesity Surgery Society of Australia and New Zealand Conference, Adelaide, SA 5-7 The Ramesh Nagappan Acute Care Medicine Course, Melbourne, VIC 6-8 AORA ASM 2017, Adelaide, SA 6-8 ASUM 47th Annual Scientific Meeting, Melbourne, VIC 7-8 RACMA Management for Clinicians – Rehabilitation for Physicians workshop, Brisbane, QLD 7-10 ASA National Scientific Congress 2017, Perth, WA 8-12 AOA 77th ASM and AGM, Adelaide, SA 9-11 Cancer Council Victoria Clinical Consultation Skills Education Retreat for Oncology Clinicians, Torquay, VIC 9-13 Activity Based Funding Conference 2017 and 33rd Patient Classification Systems International Conference 2017, Sydney, NSW 10 ASSBI 2017 webinar series: Digital health and e-health technology for ill and injured children and their families 11-13 42nd Australian and New Zealand ASM in Intensive Care and the 23rd Annual Paediatric and Neonatal Intensive Care Conference: ICU: Thinking outside the flags, Gold Coast, QLD 12-14 The Australian and New Zealand Head and Neck Cancer Society ASM, Brisbane, QLD 12-15 2017 Combined Orthopaedic Knee Societies Meeting, Noosa, QLD 13-14 Neonatal Organ Donation Workshop, Sydney, NSW 13-15 21st AMS Conference: Menopause: exploring the evidence, Sydney, NSW 13-16 RCPA 47th Annual Scientific and Business Meeting, Canberra, ACT 12-14 APELSO 2017: ECMO and beyond (the future of mechanical support), Gold Coast, QLD 14-15 RANZCP Victorian Branch Conference, Marysville, VIC 16-18 3rd International Conference on Antimicrobial Agents and Chemotherapy, Melbourne, VIC 18-19 7th National Borderline Personality Disorder Conference 2017: From stigma, to strength, Perth, WA 18-21 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma Research, Brisbane, QLD 18-21 RACMA 2017 Conference: Past reflections, future directions, Melbourne, VIC 19 Neurodevelopmental and Behavioural Paediatric Society of Australasia Leadership Development Workshop, Sydney, NSW 19-21 Rural Medicine Australia Conference, Melbourne, VIC 19-22 RANZP Faculty of Child and Adolescent Psychiatry 2017: Growing minds: The early origins of mental health and disorder, Adelaide, SA 19-22 2017 RANZCR ASM: Explore the extraordinary, Perth, WA 20 Crisis Management in Obstetric Anaesthesia and Neonatal Resuscitation, Sunshine, VIC 20 20-21 ASID Introduction to infection control and antimicrobial stewardship 2-day course, Melbourne, VIC 21-22 Australasian College of Legal Medicine Annual Scientific Meeting: The Law and Ethics of Therapeutics, Perth, WA 21-22 Update on Cardiac Arrhythmias and Devices, Sydney, NSW 22 Epworth HealthCare Seventh Cardiac Sciences Clinical Institute Symposium, Melbourne, VIC 23 10th Asian Conference on Pharmacoepidemiology, Brisbane, QLD 23-24 10th COGNO Annual Scientific Meeting, Melbourne, VIC 24-27 Australian Association of Practice Managers National Conference: The magic of management, Perth, WA 26-28 GP17 RACGP Annual conference, Sydney, NSW 26-28 SPANZA 2017 Conference, Perth, WA 27-28 6th Annual Neuropsychiatry and Behavioural Neurology Conference, Sydney NSW 27-28 RACP Northern Territory ASM, Alice Springs, NT 28-29 ASID Clinical research network spring meeting, Melbourne, VIC 28 Oct-1 Nov 49th RANZCO Annual Scientific Congress, Perth, WA 29-31 ISPE’s 10th Asian Conference on Pharmacoepidemiology, Brisbane, QLD 29 Oct-1 Nov RANZCOG Annual Scientific Meeting, Auckland, NZ November 1-3 10th Health Services and Policy Research Conference: Shifting priorities: balancing acute and primary care services, Gold Coast, QLD 1-3 Epilepsy Society of Australia 31st Annual Scientific Meeting, Perth, WA 2-4 Perioperative Medicine SIG Congress 2017: Cancer surgery and perioperative medicine: prehab to rehab, Sydney, NSW 3 Swinburne Body Image and Related Disorders (BIRD) Conference, Hawthorn campus, Melbourne, VIC 4 APS/ISPAD 10th Annual Diabetes Workshop, Gold Coast, QLD 5-6 Hepatitis C in Drug and Alcohol Settings Education Program, Canberra, ACT 7-8 20th Anniversary Showcase: National Centre for Immunisation Research and Surveillance, Sydney, NSW 8 Hammersmith Infant Neurological Examination (HINE) workshop, TBA 8-11 NZ Anaesthesia ASM 2017: Fear and excitement, Rotorua, NZ 9-10 RANZP Faculty of Psychiatry of Old Age Conference 2017, Queenstown, NZ 9-10 Hot topics in cerebral palsy research forum, Brisbane, QLD 10-12 General Practice Conference and Exhibition, Melbourne, VIC 12-15 22nd Australian and New Zealand Prevocational Medical Education Forum: Singing from the same songsheet, Brisbane, QLD 13-14 Global Experts Meeting on Gastroenterology, Melbourne, VIC 13-15 Clinical Oncology Society of Australia 2017 ASM: Immunotherapy: molecules and mountains, Sydney, NSW 13-19 Antibiotic Awareness Week 14-15 6th Annual NHMRC Symposium on Research Translation, co-hosted with the Lowitja Institute, Brisbane, QLD 14-16 2017 Annual Scientific Meeting of the Paediatric Society of New Zealand, Christchurch, NZ 15-17 Hospital in the Home Society of Australasia ASM: Changes, challenges and opportunity, Melbourne, VIC 15-17 2017 Australian & New Zealand Spinal Cord Society Annual Scientific Meeting, Brisbane, QLD 16-17 National NDIS Mental Health Conference, Sydney, NSW 16-18 ASID NZ 2017 Annual Meeting, Dunedin, NZ 17 RACP Victoria Family Christmas Lecture: Changing face of medicine as reflected in the cardiovascular health of US Presidents since World War II, Melbourne, VIC 17-18 Annual Australian Clinical Genomics Symposium 2017, Melbourne, VIC 17-18 Placebo Mechanisms Symposium, Sydney, NSW 17-19 National Histology Conference, Hobart, TAS 18 ACLM Cause of Death Certificate Workshop: Death on the Riviera, Brisbane, QLD 18-19 WA Rural Physicians’ Workshop 2017, Nedlands, WA 18-19 2017 Australasian Custodial Health Medical Officers Conference, Sydney, NSW 19-23 Australasian College for Emergency Medicine 34th ASM: Impossible is just a perspective, Sydney, NSW 20-21 11th International Conference on Immunopharmacology and Immunotoxicology: Novel development and applications in immunology and immunopharmacology, Melbourne, VIC 20-22 28th International Conference on Psychiatry and Mental Health 2017: Modernising and accomplishing mental wellness through psychology and psychiatric empathy, Melbourne, VIC 20-24 Psychiatry Update 2017, Christchurch, NZ 22-24 Rapid Stimulation Training and Essential Procedural Skills (STEPS) Course, Frankston, VIC 23-26 Asian Pacific Society of Respirology Congress 2017, Sydney, NSW 24-25 Practical Management for Clinicians with Leadership Responsibilities, Sydney, NSW 25 Monash Medicine and the Media Workshop, Melbourne, VIC 25-26 Investigations in medicine course for RACP trainees 2017, Melbourne, VIC 26-29 APCCN 2017 – Asia Pacific Conference on Clinical Nutrition, Adelaide, SA 27-29 6th National Closing the Gap Indigenous Health Conference, and 2017 National Indigenous Mental Health Conference, Cairns, QLD 30 Nov-2 Dec Mercy Perinatal Global Obstetrics Update 2017, Melbourne, VIC December 1-2 International Summit on Infectious Diseases and Antibiotics, Brisbane, QLD 1-3 ResHealth2017: 3rd International Respiratory and Sleep Medicine Conference, Adelaide, SA 2-3 ACLM Expert Witness Training Program, Brisbane, QLD 3-6 Australasian Neuroscience Society annual meeting, Sydney, NSW 3-8 MICROMON Molecular Biology Techniques 2017, Melbourne, VIC 6 AHHA Data and Innovation Collaboration Network Meeting, Dubbo, NSW 6-8 Sydney Cardiovascular Symposium 2017, Sydney, NSW 7-8 CPET and Prehabilitation Symposium: Incorporating POETTS (UK) accredited CPET course, Melbourne, VIC 7-12 Melbourne Neuro and Orthopaedic MRI Course, Melbourne, VIC 8-10 Entheogenesis Australis Outdoor Psychedelic Symposium, Eildon, VIC 12 ASSBI 2017 Webinar Series - Rare and Unusual Syndromes 2018 February 4-8 World Congress on Phlebology, Melbourne, VIC 7-9 National Indigenous Men’s Health Conference, National Indigenous Women’s Wellbeing Conference, Sydney, NSW 9-10 4th International 4 Corners of Cardiology Meeting, Melbourne, VIC 17 4th Australian Paediatric Society Allergy Masterclass, Melbourne, VIC 23-24 PICET Obstetric Intensive Care Symposium, Adelaide, SA 25-28 World Psychiatric Association 2018 Thematic Conference: Innovation in Psychiatry: Effective interventions for health and society, Melbourne, VIC 26 Feb-2 Mar Leadership and Innovation in Health 2017, Melbourne, VIC March 2-4 Pathology Update 2018, Sydney, NSW 2-4 Medical Parents of Australia and New Zealand Conference, Melbourne, VIC 8-11 APSCVIR 2018, Auckland, NZ 25-28 12th International Symposium on Medical Information and Communication Technology, Sydney, NSW 28-30 7th National Indigenous Domestic Violence Conference, Gold Coast, QLD April 7-8 2018 Neuromodulation Society of Australia and New Zealand 13th ASM, Sydney, NSW 11-13 2nd International Selection in the Health Professions Conference, Melbourne, VIC 18-20 New Zealand Population Health Congress 2018, Auckland, NZ 22-27 Hunter Paediatric Society Conference, Palm Cove, QLD May 7-11 Royal Australasian College of Surgeons Annual Scientific Congress 2018: Reflecting on what really matters, Sydney, NSW 13-17 RANZP Congress 2018: Becoming well together: Partnerships in health, Auckland, NZ 18-22 Australasian College of Dermatologists ASM, Gold Coast, QLD 20-23 5th Asian and Oceanic Regional Congress on Radiation Protection, Melbourne, VIC 30 May-1 Jun National Medicines Symposium, Canberra, ACT June 7-9 Rural Doctors Association of Queensland 29th Annual Conference, TBC August 15-18 World Congress on Cancers of the Skin, Sydney, NSW September 13-14 NOSA Annual Meeting 2018, Melbourne, VIC 15-16 Neurovision, Melbourne, VIC October 6-9 ASA National Scientific Congress 2018, Adelaide, SA 10-12 IHF World Hospital Congress 2018, Brisbane, QLD 25-28 2018 RANZCR ASM, Canberra, ACT November 8-10 New Zealand Anaesthesia Annual Scientific Meeting 2018, Auckland, NZ 8-10 RANZCP Faculty of Psychiatry of Old Age and the Asian Society Against Dementia Conference 2018, Melbourne, VIC 13-15 Clinical Oncology Society of Australia 2018 ASM, Perth, WA 18-22 Australasian College for Emergency Medicine, 35th ASM, Perth, WA 26-28 1st International Motor Impairment Conference, Sydney, NSW 2019 November 17-19 10th World Congress of Itch, Sydney, NSW 2021 November 10-13 XIII International Congress of Dermatology, Melbourne, VIC December TBA FIGO World Congress of Gynaecology and Obstetrics, Sydney, NSW
Cate Swannell
News briefs
Cate Swannell
Health care variation: the next challenge for clinical colleges
Helen Francombe · Heather A Buchan · Anne Duggan
Vertebroplasty for acute painful osteoporotic fracture
Paul Bird · Terrence Diamond · William A Clark
Tripe palms: a cutaneous manifestation of internal malignancy
Anver M Sethwala
News briefs
Cate Swannell
Improving the safety of breast implants: implant-associated lymphoma
Ingrid Hopper · Susannah Ahern · John J McNeil · Anand K Deva · Elisabeth Elder · Colin Moore · Rodney Cooter
Statistical and clinical significance
Ian A Scott
Corynebacterium minutissimum infection: erythrasma
Deshan F Sebaratnam · Stephen Lee